Search Back New search Go to resultsDiseaseMain groupHematological Diseases, Non-MalignantProtocol groupAnemias, CytopeniasDiseaseBeta ThalassemiaSubgroupICD10D56.-D56.1D56.3MeSHSequenceChemotherapyChemo-substanceChemo-substanceChemo-substanceChemo-substanceNo. Substances RadiotherapySupportive therapySupportive substanceLuspaterceptSupportive substanceLuspaterceptSupportive substanceLuspaterceptSupportive substanceLuspaterceptNo. Substances1Protocol classificationTherapy classificationcurrent standardIntensityStandard doseTherapy indicationseveral possibleTherapy phaseTherapy intentionsupportiveRisksDiarrheaPainUpper Respiratory Tract Infection only studiesPublicationAuthorCappellini MDDiseasetransfusionsabhängige Anämie bei beta-ThalassämieOriginDepartment of Clinical Sciences and Community, University of Milan, Milan, Italy, BELIEVEProtocols in Revision 1 protocol foundProtocols under revision.Luspatercept 1.0, Beta Thalassemia (PID1535 V1.1)
